USPTO serial 87591008
LB
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAI, TINA HSIN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NANJING LEGEND BIOTECH CO., LTD.
Park Jiangning Dist., CN
NANJING LEGEND BIOTECH CO., LTD.
Park Jiangning Dist., CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Alumit
JOHN ALUMIT ALUMIT IP135 S. JACKSON STREET, SUITE 200GLENDALE, CA 91205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | (Based on Intent to Use) pharmaceutical preparations for treating Multiple Myeloma, blood cancer and solid tumor; chemico-pharmaceutical preparations for treating Multiple Myeloma, blood cancer and solid tumor; drugs for medical purposes for treating Multiple Myeloma, blood cancer and solid tumor; serotherapeutic medicines; biological preparations for medical purposes for treating Multiple Myeloma, blood cancer and solid tumor; chemical preparations for pharmaceutical purposes for treating Multiple Myeloma, blood cancer and solid tumor; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical drug for treating Multiple Myeloma, blood cancer and solid tumor; Blood products, namely, blood plasma | ACTIVE | — |
| 042 | (Based on Use) Technical research in the field of pharmaceutical studies; Consulting services for others in the field of design, planning, and implementation project management of scientific research; research and development of new products for others; scientific laboratory services; scientific research; chemical analysis; Chemistry consultation; chemical research; bacteriological research; biological research | ACTIVE | May 13, 2017 |
| 044 | (Based on Use) medical clinic services; medical assistance; telemedicine services; Medical, physical rehabilitation and physical therapy services; preparation of prescriptions by pharmacists; hospital services; health care; Medical and pharmaceutical consultation; nursing, medical; Veterinary services | ACTIVE | May 13, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NANJING LEGEND BIOTECH CO., LTD.
- Other trademarks owned by NANJING LEGEND BIOTECH CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LB
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 11, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 11, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 10, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 15, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 15, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 2, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 29, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 15, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 8, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2017 | NWAP | NEW APPLICATION ENTERED | — |